-
1 Comment
Fresenius Medical Care AG & Co. KGaA is currently in a long term uptrend where the price is trading 3.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.
Fresenius Medical Care AG & Co. KGaA's total revenue sank by 3.9% to $4B since the same quarter in the previous year.
Its net income has dropped by 48.3% to $177M since the same quarter in the previous year.
Finally, its free cash flow fell by 35.9% to $278M since the same quarter in the previous year.
Based on the above factors, Fresenius Medical Care AG & Co. KGaA gets an overall score of 2/5.
Industry | Medical Care Facilities |
---|---|
Sector | Healthcare |
CurrencyCode | EUR |
Exchange | F |
ISIN | DE0005785802 |
Dividend Yield | 2.7% |
---|---|
Target Price | None |
PE Ratio | 18.51 |
Beta | 0.88 |
Market Cap | 12B |
Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for FME.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024